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Abstract
A key question in clinical practice is accurate prediction of patient prognosis. To this end,
nowadays, physicians have at their disposal a variety of tests and biomarkers to aid them
in optimizing medical care. These tests are often performed on a regular basis in order to
closely follow the progression of the disease. In this setting it is of medical interest to op-
timally utilize the recorded information and provide medically-relevant summary measures,
such as survival probabilities, that will aid in decision making. In this work we present and
compare two statistical techniques that provide dynamically-updated estimates of survival
probabilities, namely landmark analysis and joint models for longitudinal and time-to-event
data. Special attention is given to the functional form linking the longitudinal and event
time processes, and to measures of discrimination and calibration in the context of dynamic
prediction.
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1 Introduction
Nowadays there is great interest in accurate risk assessment for prevention and treatment of
disease. Physicians use risk scores to reach appropriate decisions, such as prescribing treat-
ment, or extra medical tests or suggesting alternative therapies. Patients who are informed
about their health risk often decide to adjust their lifestyles to mitigate it. Risk scores are
typically based on several factors that describe the patients’ physical condition, such as age,
BMI, smoking, genetic predisposition, and the results of medical tests. In this work we focus
on the use of the results of such tests and more specifically on biomarkers. The majority
of prognostic models in the medical literature utilize only a small fraction of the available
biomarker information. In particular, even though biomarkers are measured repeatedly over
time, risk scores are typically based on the last available biomarker measurement. It is
evident that such an approach discards valuable information because it does not take into
account that the rate of change in the biomarker levels is not only different from patient to
patient but also dynamically changes over time for the same patient. Hence, it is medically
relevant to investigate whether repeated measurements of a biomarker can provide a better
understanding of disease progression and a better prediction of the risk for the event of
interest than a single biomarker measurement.
In line with the previous arguments, the motivation for this research comes from a study
conducted by the Department of Cardio-Thoracic Surgery of the Erasmus Medical Center
in the Netherlands. This study includes 285 patients who received a human tissue valve in
the aortic position in the hospital from 1987 until 2008 (Bekkers et al. 2011). Aortic allo-
graft implantation has been widely used for a variety of aortic valve or aortic root diseases.
Major advantages ascribed to allografts are the excellent hemodynamic characteristics as a
valve substitute; the low rate of thrombo-embolic complications, and, therefore, absence of
the need for anticoagulant treatment; and the resistance to endocarditis. A major disad-
vantage of using human tissue valves, however is the susceptibility to degeneration and the
concomitant need for re-interventions. The durability of a cryopreserved aortic allograft is
age-dependent, leading to a high lifetime risk of re-operation, especially for young patients.
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Re-operations on the aortic root are complex, with substantial operative risks, and mortality
rates in the range 4–12%. It is therefore of great interest for cardiologists and cardio-thoracic
surgeons to have at their disposal an accurate prognostic tool that will inform them about
the future prospect of a patient with a human tissue valve in order to optimize medical care,
carefully plan re-operation and minimize valve-relate morbidity and mortality.
From the statistical analysis viewpoint the challenge is to utilize a technique capable
of updating estimates of survival probabilities for a new patient as additional longitudinal
information is recorded. An early approach in solving this problem has been landmarking
(Anderson et al. 1983; Zheng and Heagerty 2005; van Houwelingen 2007). The basic idea
behind landmarking is to obtain survival probabilities from a Cox model fitted to the patients
from the original dataset who are still at risk at the time point of interest (e.g., the last
time point we know that the new patient was still alive). A relatively newer method for
producing dynamic predictions of survival probabilities is based on the class of joint models
for longitudinal and time-to-event data (Henderson et al. 2002; Yu et al. 2008; Proust-Lima
and Taylor 2009; Rizopoulos 2011, 2012b). In these models we have a complete specification
of the joint distribution of the longitudinal response and the event times based on which the
predictions in question can be derived. The main aim of this paper is to further study and
contrast these two approaches. In particular, we show how survival probabilities are obtained
under each method and what the differences are in the underlying assumptions. In addition,
we focus on the functional relationship between the two processes and how this may affect
predictions. We surpass the standard formulation, which only includes the current value
of the marker, and we postulate functional forms that allow the rate of increase/decrease
of the longitudinal outcome or a suitable summary of the whole longitudinal trajectory to
determine the risk for an event. To assess the quality of the derived predictions from the two
approaches we present different measures of discrimination and calibration, suitably adjusted
to the context of longitudinal biomarkers.
The rest of the paper is organized as follows. Section 2 describes formally the context of
dynamic predictions and presents the landmarking and joint modeling approaches. Section 3
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shows different options for the functional form of the association structure between the
longitudinal and event time processes. Section 4 presents measures of discrimination and
calibration adapted to the dynamic predictions setting. Section 5 illustrates the use of joint
modeling and landmarking in the Aortic Valve dataset and Section 6 refers to the results of
a simulation study. Finally, Section 7 concludes the paper.
2 Dynamic Individualized Predictions
Following the discussion in Section 1 and the motivation from the Aortic Valve dataset,
we present here the two frameworks for deriving dynamic individualized predictions. Let
Dn = {Ti, δi,yi; i = 1, . . . , n} denote a sample from the target population, where T ∗i denotes
the true event time for the i-th subject (i = 1, . . . , n), Ci the censoring time, Ti = min(T
∗
i , Ci)
the corresponding observed event time, and δi = I(T
∗
i ≤ Ci) the event indicator, with I(·)
being the indicator function that takes the value 1 when T ∗i ≤ Ci, and 0 otherwise. In
addition, we let yi denote the ni × 1 longitudinal response vector for the i-th subject,
with element yil denoting the value of the longitudinal outcome taken at time point til,
l = 1, . . . , ni.
We are interested in deriving predictions for a new subject j from the same population
that has provided a set of longitudinal measurements Yj(t) = {yj(tjl); 0 ≤ tjl ≤ t, l =
1, . . . , nj}, and has a vector of baseline covariateswj. The fact that biomarker measurements
have been recorded up to t, implies survival of this subject up to this time point, meaning
that it is more relevant to focus on the conditional subject-specific predictions, given survival
up to t. In particular, for any time u > t we are interested in the probability that this new
subject j will survive at least up to u, i.e.,
pij(u | t) = Pr(T ∗j ≥ u | T ∗j > t,Yj(t),wj,Dn).
The time-dynamic nature of pij(u | t) is evident because when new information is recorded
for patient j at time t′ > t, we can update these predictions to obtain pij(u | t′), and therefore
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proceed in a time-dynamic manner.
2.1 Landmarking
The landmarking approach provides an estimate of pij(u | t) by selecting the subjects at risk
at t from the original dataset Dn, and using these to derive predictions. More formally, let
R(t) = {i : Ti > t} denote the adjusted risk set, including all subjects who were not censored
or dead by the landmark time t. Then a Cox model is fitted to these subjects by resetting
time with zero being the landmark time, i.e.,
hi(u− t) = lim
∆t→0
1
∆t
Pr
{
u− t ≤ T ∗i < u− t+ ∆t | T ∗i > u− t,Yi(t)
}
= h0(u− t) exp
{
γ>wi + αy˜i(t)
}
, u > t,
where the baseline hazard function h0(·) is assumed completely unspecified, wi denotes a
vector of baseline covariates, and the last available longitudinal response y˜i(t) also enters
into the model as an ordinary baseline covariate. Having fitted this Cox model, an estimate
of pij(u | t) is simply obtained by means of the Breslow estimator:
pˆiLMj (u | t) = exp
[
−Ĥ0(u) exp{γ̂>wj + αˆy˜j(t)}
]
, (1)
where
Ĥ0(u) =
∑
i∈R(t)
I(Ti ≤ u)δi∑
`∈R(u) exp{γ̂>w` + αˆy˜`(t)}
.
van Houwelingen (2007) and Zheng and Heagerty (2005) discuss several extensions of this
approach that have greater flexibility by allowing the regression coefficient α to depend on
time, i.e.,
hi(u− t) = h0(u− t) exp
{
γ>wi + α(u− t)y˜i(t)
}
,
and also, possibly, a baseline hazard that is not only a function of the time since the last
measurement u − t, but also a function of the measurement time t, relaxing thus the pro-
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portional hazards assumption. An advantage of landmarking is that it can be very easily
applied in practice, because it only requires fitting a simple Cox model each time a new
measurement has been recorded for the subject for whom predictions are of interest.
2.2 Joint Modeling
Contrary to the landmark approach, in the framework of joint models for longitudinal and
time-to-event data we have a complete specification of the joint distribution of the two
outcomes (Faucett and Thomas 1996; Wulfsohn and Tsiatis 1997; Henderson et al. 2000;
Tsiatis and Davidian 2004; Rizopoulos 2012b). For the longitudinal biomarker measurements
mixed-effects models are typically employed to describe the subject-specific longitudinal
trajectories. For simplicity of exposition and because the marker that we are going to use
for the Aortic Valve dataset, namely the aortic gradient, is a continuous one, we focus here
on linear mixed-effects models,
yi(t) = mi(t) + εi(t) = x
>
i (t)β + z
>
i (t)bi + εi(t),
bi ∼ N (0,D), εi(t) ∼ N (0, σ2),
(2)
where yi(t) denotes the observed value of the longitudinal outcome at any particular time
point t, xi(t) and zi(t) denote the time-dependent design vectors for the fixed-effects β
and for the random effects bi, respectively, and εi(t) the corresponding error terms that are
assumed independent of the random effects, and cov{εi(t), εi(t′)} = 0 for t′ 6= t. For the
survival process, we assume that the risk for an event depends on the ‘true’ and unobserved
value of the marker at time t (i.e., excluding the measurement error), denoted by mi(t) in
(2). More specifically, we have
hi(t | Mi(t),wi) = lim
∆t→0
1
∆t
Pr{t ≤ T ∗i < t+ ∆t | T ∗i ≥ t,Mi(t),wi}
= h0(t) exp
{
γ>wi + αmi(t)
}
, t > 0, (3)
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where Mi(t) = {mi(s), 0 ≤ s < t} denotes the history of the true unobserved longitudinal
process up to t, h0(·) denotes the baseline hazard function, and, as before, wi is a vector
of baseline covariates with corresponding regression coefficients γ. Parameter α quantifies
the association between the true value of the marker at t and the hazard for an event
at the same time point. Estimation of joint model’s parameters can be based either on
maximum likelihood or a Bayesian approach using Markov chain Monte Carlo algorithms.
The likelihood of the model is derived under the assumptions that given the random effects,
both the longitudinal and event time process are assumed independent, and the longitudinal
responses of each subject are assumed independent. Formally we have,
p(yi, Ti, δi | bi,θ) = p(yi | bi,θ) p(Ti, δi | bi,θ), (4)
p(yi | bi,θ) =
∏
l
p(yil | bi,θ), (5)
where θ> = (θ>t ,θ
>
y ,θ
>
b ) denotes the full parameter vector, with θt denoting the parameters
for the event time outcome, θy the parameters for the longitudinal outcomes, and θb the
unique parameters of the random-effects covariance matrix, and p(·) denotes an appropriate
probability density function. More details regarding the estimation and properties of joint
models can be found in Rizopoulos (2012b) and Ibrahim et al. (2001, Chapter 7).
Under this framework, estimation of pij(u | t) can be based on (asymptotic) Bayesian
arguments and the corresponding posterior predictive distribution:
pij(u | t) =
∫
Pr(T ∗j ≥ u | T ∗j > t,Yj(t),θ) p(θ | Dn) dθ.
The calculation of the first part of each integrand takes full advantage of the conditional
independence assumptions (4) and (5). In particular, we observe that the first term of the
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integrand of pij(u | t) can be rewritten by noting that:
Pr(T ∗j ≥ u | T ∗j > t,Yj(t),θ) =
∫
Pr(T ∗j ≥ u | T ∗j > t, bj,θ) p(bj | T ∗j > t,Yj(t),θ) dbj
=
∫
Sj
{
u | Mj(u, bj),θ
}
Sj
{
t | Mj(t, bj),θ
} p(bj | T ∗j > t,Yj(t),θ) dbj,
where
Sj
{
t | Mj(t, bj),θ
}
= exp
{∫ t
0
h0(s) exp{γ>wi + αmi(s)}
}
ds,
denotes the subject-specific survival function.
Combining these equations with the maximum likelihood estimates or with the MCMC
sample from the posterior distribution of the parameters for the original data Dn, we can
devise a simple simulation scheme to obtain a Monte Carlo estimate of pij(u | t). More
specifically, this is comprised of the following steps:
Step 1. Take K samples of {θ(k), k = 1, . . . , K} from either the MCMC sample of p(θ | Dn) or
the asymptotic normal posterior distribution N (θ̂,Hn), where θ̂ denotes the maximum
likelihood estimates and Hn the observed information matrix
Hn =
{
−
n∑
i=1
∂2 log p(yi, Ti, δi,θ)
∂θ>∂θ
∣∣∣
θ=θˆ
}−1
.
Step 2. Draw K realizations {b(k)j , k = 1, . . . , K} for the random effects of the new subject j
from the posterior distribution of the random effects
p
(
bj | T ∗j > t,Yj(t),θ(k)
) ∝ {nj(t)∏
l=1
p
(
yjl | bj,θ(k)
)}
Sj
{
t | Mj(t, bj),θ(k)
}
p
(
bj,θ
(k)
)
,
where nj(t) denotes the number of available measurements for subject j by time t.
Step 3. Based on these realizations an estimate of pij(u | t) is derived as
pˆiJMj (u | t) =
1
K
K∑
k=1
Sj
{
u | Mj(u, b(k)j ),θ(k)
}
Sj
{
t | Mj(t, b(k)j ),θ(k)
} . (6)
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More details can be found in Yu et al. (2008) and Rizopoulos (2011, 2012b).
2.3 Heuristic Comparison between Landmarking and Joint Mod-
eling
The previous two sections illustrated that both landmarking and joint modeling can be uti-
lized to derive dynamically updated estimates of conditional survival probabilities pij(u | t).
The landmark approach can be more easily implemented in practice because it only requires
fitting a standard Cox model, whereas joint models require specialized software (Rizopoulos
2010, 2012b). In addition, joint models seem to make more modeling assumptions than
the landmark approach, which poses a concern regarding how a misspecification of these
assumptions may affect predictions. On the other hand, the landmark approach uses less in-
formation than joint modeling (i.e., only the last observed longitudinal response), and hence
is less optimal. The following points provide a more detailed exposition of the underlying
differences between the two approaches.
• Extrapolation: The main differences in how landmarking and joint modeling tackle
the problem of prediction can best be explained by Figure 1. This shows the lon-
gitudinal responses of a hypothetical subject who was alive up to year five and for
whom we would like to obtain a predicted survival function. To produce estimates of
the conditional survival probabilities both landmarking and joint modeling require a
value for the longitudinal response at t = 5 (vertical dotted line). Since this subject
provided her last longitudinal measurement at year three, some sort of extrapolation is
taking place. In particular, landmarking is based on a ‘last value carried forward’ ap-
proach and uses as the value of the longitudinal response at year five the last available
measurement of the subject at year three (horizontal dashed line). Even though this
approach is conceptually simple and easy to perform in practice, unfortunately, it may
lead to biased and misleading inference on the Cox model parameters (Tsiatis and Da-
vidian 2001). Joint modeling on the other hand uses the subject-specific fitted value
of the longitudinal profile from the linear mixed model extrapolated at year 5, i.e.,
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mj(5) = x
>
j (5)β + z
>
j (5)bj (solid line). This approach uses all available information,
because the estimate of mj(5) is based on both all past values of this subject and on
the responses of other subjects. To explain how the borrowing of information between
subjects is taking place, assume, hypothetically, that there was another patient, who
during the first three years had exactly the same longitudinal measurements as the
patient depicted in Figure 1, but also she had extra measurements up to year five. The
joint model would make use of this patient and say that the profile of the patient in
Figure 1 would be similar to the one of the patient with the extra measurements. From
a biological point of view the joint modeling approach seems more logical than land-
marking because we indeed expect the biomarker levels of a patient to continuously
change over time rather than to remain constant between visits.
Note that in general even if we had observed the longitudinal response at t = 5, i.e.,
yj(5) this will not be equal to mj(5). The joint model assumes that the realizations
of the longitudinal marker are the output of a stochastic process generated by the
subject, and it is the underlying signal in the process, represented by mj(t), that is
associated with the hazard for an event. The observed data yj(t) are a contaminated
with measurement error version of the underlying signal mj(t). This measurement error
most often stems from biological variation, but some times may also be attributed to
the medical test/examination used to measure the marker.
• Assumptions related to the longitudinal process: The landmark approach as-
sumes that the visiting process, which is the process, stochastic or deterministic, that
generates the visit times at which subjects provide measurements is independent of
the longitudinal marker process and the survival time T ∗j . The joint modeling ap-
proach also assumes that a visit scheduled at time t is independent of a future event
occurring at T ∗j > t and of future longitudinal responses {yj(s), t ≤ s ≤ T ∗j }, but it
does allow visit times to depend on the observed longitudinal responses Yj(t). This
is a more realistic assumption because what we expect to happen in practice is that
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Figure 1: Graphical comparison on how landmarking and joint modeling use the available
longitudinal measurements to provide an estimate of the longitudinal outcome at the last
time point the patients was still alive. The left side of the plot shows the observed longitudi-
nal responses, and the fitted longitudinal profile from the joint model. The right side shows
the corresponding survival probability.
physicians will ask a patient to come back more often if they observe a worsening of
her condition based on her observed responses. In addition, subjects may have miss-
ing marker measurements during follow-up. The landmark approach assumes that any
such missingness is completely at random (Little and Rubin 2002). On the other hand,
due to the fact that joint modeling is based on a complete specification of the joint
likelihood function of the longitudinal and event time processes, it allows incomplete
longitudinal data to be missing at random. Hence, joint modeling is capable of pro-
viding valid inferences under less stringent assumptions than landmarking. Though,
it should be mentioned that these advantageous features require the joint model to be
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roughly correctly specified.
• Assumptions related to the event process: Similarly to the assumptions for the
longitudinal process, landmarking makes more stringent assumptions for the censoring
process. In particular, under the landmark approach censoring is assumed independent
of past longitudinal responses {yj(s); 0 ≤ s < t}, whereas under joint modeling and
again because we use a complete specification of the joint likelihood function, censoring
is allowed to depend in a general way on {yj(s); 0 ≤ s < t}.
3 Functional Form
The assessment of the predictive value of baseline covariates is to a degree simple, in the sense
that these covariates are typically included in a prognostic model as is or under a suitable
transformation (e.g., log-scale, polynomials, splines, etc.). However, in our setting, where
we have multiple longitudinal measurements available per subject there could be different
features of the longitudinal process that are most predictive for the event of interest. For
example, in ordinary proportional hazards models, it has been long recognized that the
functional form of time-varying covariates influences the derived inferences; see, for instance,
Fisher and Lin (1999) and references therein. In the joint modeling framework however,
where the longitudinal outcome plays the role of a time-dependent covariate for the survival
process, this topic has received less attention. The two main functional forms that have
been primarily used so far in joint models include in the linear predictor of the relative risk
model (3) either the subject-specific means mi(t) from the longitudinal submodel or just the
random effects bi (Henderson et al. 2000; Rizopoulos and Ghosh 2011). However, as argued
above, there could be other characteristics of the patients’ longitudinal profiles that are more
predictive for the risk of an event, such as the rate of increase/decrease of the biomarker’s
levels or a suitable summary of the whole longitudinal trajectory. Here we present a few
examples of alternative formulations for the association structure between the longitudinal
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outcome and the risk for an event:
hi(t) = h0(t) exp
{
γ>wi + α1mi(t) + α2m′i(t)
}
, m′i(t) =
dmi(t)
dt
, (7)
hi(t) = h0(t) exp
{
γ>wi + α
∫ t
0
mi(s) ds
}
, (8)
hi(t) = h0(t) exp
{
γ>wi + α
∫ t
0
%(t− s)mi(s) ds
}
, (9)
hi(t) = h0(t) exp(γ
>wi +α>bi). (10)
It is evident that these parameterizations have different sets of association parameters α,
and in addition that the interpretation of these parameters is different for each formulation.
In particular, parameterization (7) postulates that the risk for an event at a particular
time point t depends not only on the level of the marker at this time point but also on
its rate of change, captured by the slope term m′i(t). This could be of importance when
two patients at a specific time point have equal marker levels, but one patient having an
increasing trajectory and the other a decreasing one. Parameterization (8) posits that the
risk for an event at time t is associated with the area under the longitudinal trajectory up
to this point. This can be considered as a summary of the whole marker history up to t and
contrary to the previous formulations it allows the risk to the depend on the whole history
Mi(t) = {mi(s), 0 ≤ s < t} and not only on features of the marker at t. Parameterization
(9) extends (8) by assigning to the past values of the longitudinal trajectory different weights,
using a function %(·). For instance, setting %(t− s) = φ(t− s)/{Φ(t)−0.5}, where 0 < s < t,
and φ(·) and Φ(·) denote the probability density and cumulative distribution functions of
the standard normal distribution, respectively, we assume that the risk at t only depends
on the marker levels in the interval (t − 3, t) with values closer to t having higher weight,
because when t − s > 3 then %(t − s) is practically zero. Finally, parameterization (10) is
time-independent and assumes that the hazard for an event is related to the random effects
from the longitudinal process. This formulation shares similarities with the time-dependent
slopes parameterization (7) when a simple random-intercepts and random-slopes structure
is assumed for the longitudinal submodel.
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Under the landmarking approach, and in order to improve predictive performance, we
could also make better use of the observed longitudinal history than just using the last
available measurement. Mimicking the formulations presented above for joint modeling, we
can define Cox models fitted to the patients at risk at the landmark time t, which include
y˜′i(t) that denotes the slope calculated from the last two available measurements of each
subject, and
∑
0≤s≤t yi(s)∆s that denotes the area under the step function defined from the
observed longitudinal measurements up to t:
hi(u− t) = h0(u− t) exp
{
γ>wi + α1y˜i(t) + α2y˜′i(t)
}
,
hi(u− t) = h0(u− t) exp
{
γ>wi + α
t∑
s=0
yi(s)∆s
}
,
hi(u− t) = h0(u− t) exp
{
γ>wi + α
t∑
s=0
%(t− s)yi(s)∆s
}
,
where, as before, %(t − s) is a potential weight function. Note that we do not have an
analogous functional form to (10) under landmarking.
4 Measuring Predictive Performance
The assessment of the predictive performance of time-to-event models has received a lot of
attention in the statistical literature. In general, the developed methodology has focused on
calibration, i.e., how well the model predicts the observed data (Schemper and Henderson
2000; Gerds and Schumacher 2006) or discrimination, i.e., how well can the model discrim-
inate between patients that had the event from patients that did not (Harrell et al. 1996;
Pencina et al. 2008). In the following we present discrimination and calibration measures
suitably adapted to the dynamic prediction setting. It should be noted that these measures
require in their essence an estimate of pij(u | t), and therefore they are applicable under both
landmarking and joint modeling. In the following we will use the term pˆij(u | t) to generically
denote either (1) or (6).
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4.1 Discrimination
To take into account the dynamic nature of the longitudinal marker in discriminating between
subjects, we focus on a time interval of medical relevance within which the occurrence of
events is of interest. In this setting, a useful property of the model would be to successfully
discriminate between patients who are going to experience the event within this time frame
from patients who will not. To put this formally, as before, we assume that we have collected
longitudinal measurements Yj(t) = {yj(tjl); 0 ≤ tjl ≤ t, l = 1, . . . , nj} up to time point t
for subject j. We are interested in events occurring in the medically-relevant time frame
(t, t + ∆t] within which the physician can take an action to improve the survival chance
of the patient. Under the assumed model and the methodology presented in Section 2,
we can define a prediction rule using pij(t + ∆t | t) that takes into account the available
longitudinal measurements Yj(t). In particular, for any value c in [0, 1] we can term subject
j as a case if pij(t+ ∆t | t) ≤ c (i.e., occurrence of the event) and analogously as a control if
pij(t+ ∆t | t) > c. Thus, in this context, we define sensitivity and specificity as
Pr
{
pij(t+ ∆t | t) ≤ c | T ∗j ∈ (t, t+ ∆t]
}
,
and
Pr
{
pij(t+ ∆t | t) > c | T ∗j > t+ ∆t
}
,
respectively. For a randomly chosen pair of subjects {i, j}, in which both subjects have
provided measurements up to time t, the discriminative capability of the assumed model can
be assessed by the area under the receiver operating characteristic curve (AUC), which is
obtained for varying c and equals,
AUC(t,∆t) = Pr
[
pii(t+ ∆t | t) < pij(t+ ∆t | t) | {T ∗i ∈ (t, t+ ∆t]} ∩ {T ∗j > t+ ∆t}
]
,
that is, if subject i experiences the event within the relevant time frame whereas subject j
does not, then we would expect the assumed model to assign higher probability of surviving
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longer than t + ∆t for the subject who did not experience the event. To summarize the
discriminative power of the assumed model over the whole follow-up period, we need to
take into account that the number of subjects contributing to the comparison of the fitted
pii(t + ∆t | t) with the observed data is not the same for all time points t. Following an
approach similar to Antolini et al. (2005) and Heagerty and Zheng (2005), we propose the
use of a weighted average of AUCs
C∆tdyn =
∫ ∞
0
AUC(t,∆t) Pr{E(t)} dt
/∫ ∞
0
Pr{E(t)} dt, (11)
where E(t) = [{T ∗i ∈ (t, t + ∆t]} ∩ {T ∗j > t + ∆t}], and Pr{E(t)} denotes the probability
that a random pair is comparable at t. We call C∆tdyn the dynamic concordance index since
it summarizes the concordance probabilities over the follow-up period. Note also that C∆tdyn
depends on the length ∆t of the time interval of interest, which implies that different models
may exhibit different discrimination power for different ∆t.
For the estimation of C∆tdyn we need to take care of two issues, namely, the calculation
of the integrals in the definition of (11) and censoring. For the former we use a 15-point
Gauss-Kronrod quadrature rule (Press et al. 2007). To take into account the fact that the
number of subjects decreases over time due to the occurrence of events and censoring, for
any time point t we define as comparable pairs the pairs that satisfy the relation
Ωij(t) =
[{Ti ∈ (t, t+ ∆t]} ∩ {δi = 1}] ∩ {Tj > t+ ∆t} or[{Ti ∈ (t, t+ ∆t]} ∩ {δi = 1}] ∩ [{Tj = t+ ∆t} ∩ {δj = 0}],
where i, j = 1, . . . , n with i 6= j. For two comparable subjects i and j, we can estimate
and compare their survival probabilities pii(t + ∆t | t) and pij(t + ∆t | t), based on the
methodology presented in Section 2. This leads to a natural estimator for AUC(t,∆t) as the
proportion of concordant subjects out of the set of comparable subjects for time t:
AÛC(t,∆t) =
∑n
i=1
∑n
j=1;j 6=i I{pˆii(t+ ∆t | t) < pˆij(t+ ∆t | t)} × I{Ωij(t)}∑n
i=1
∑n
j=1;j 6=i I{Ωij(t)}
,
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where I(·) denotes the indicator function. Having estimated AUC(t,∆t), the next step in
estimating C∆tdyn is to obtain estimates for the weights Pr{E(t)}. We observe that these can
be rewritten as
Pr{E(t)} = Pr[{T ∗i ∈ (t, t+ ∆t]} ∩ {T ∗j > t+ ∆t}]
= Pr(T ∗i ∈ (t, t+ ∆t])× Pr(T ∗j > t+ ∆t)
= {S(t)− S(t+ ∆t)}S(t+ ∆t),
where the simplification in the second line comes from the independence of subjects i and j,
and S(·) here denotes the marginal survival function.
In practice the calculation of C∆tdyn is restricted into a follow-up interval [0, tmax] where we
have information. Let t1, . . . , t15 denote the re-scaled abscissas of the Gauss-Kronrod rule
in the interval [0, tmax] with corresponding weights $1, . . . , $15. We combine the estimates
AÛC(tk,∆t), k = 1, . . . , 15 with the estimates of the weights Pr{E(t)} to obtain
Ĉ
∆t
dyn =
∑15
k=1$kAÛC(tk,∆t)× P̂r{E(tk)}∑15
k=1$kP̂r{E(tk)}
,
where P̂r{E(tk)} = {Ŝ(tk) − Ŝ(tk + ∆t)}Ŝ(tk + ∆t), with Ŝ(·) denoting the Kaplan-Meier
estimate of the marginal survival function S(·).
4.2 Calibration
The assessment of the accuracy of predictions of survival models is typically based on the
expected error of predicting future events. In our setting, and again taking into account
the dynamic nature of the longitudinal outcome, it is of interest to predict the occurrence
of events at u > t given the information we have recorded up to time t. This gives rise to
expected prediction error:
PE(u | t) = E[L{Ni(u)− pii(u | t)}],
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where Ni(t) = I(T
∗
i > t) is the event status at time t, L(·) denotes a loss function, such as
the absolute or square loss, and the expectation is taken with respect to the distribution of
the event times. An estimate of PE(u | t) that accounts for censoring has been proposed by
Henderson et al. (2002):
P̂E(u | t) = {n(t)}−1
∑
i:Ti≥t
I(Ti ≥ u)L{1− pˆii(u | t)}+ δiI(Ti < u)L{0− pˆii(u | t)}
+(1− δi)I(Ti < u)
[
pˆii(u | Ti)L{1− pˆii(u | t)}+ {1− pˆii(u | Ti)}L{0− pˆii(u | t)}
]
,
where n(t) denotes the number of subjects at risk at time t. The first two terms in the sum
correspond to patients who were alive after time u and dead before u, respectively; the third
term corresponds to patients who were censored in the interval [t, u]. Using the longitudinal
information up to time t, PE(u | t) measures the predictive accuracy at the specific time
point u. Alternatively, we could summarize the error of prediction in a specific interval of
interest, say [t, u], by calculating a weighted average of {PE(s | t), t < s < u} that corrects
for censoring, similarly to C∆tdyn. An estimator of this type for the integrated prediction error
has been suggested by Schemper and Henderson (2000), which adapted to our time-dynamic
setting takes the form
IP̂E(u | t) =
∑
i:t≤Ti≤u δi
{
ŜC(t)/ŜC(Ti)
}
P̂E(u | t)∑
i:t≤Ti≤u δi
{
ŜC(t)/ŜC(Ti)
} ,
where ŜC(·) denotes the Kaplan-Meier estimator of the censoring time distribution.
Both IP̂E(u | t) and P̂E(u | t) can be used to provide a measure of explained variation
between nested models. Assuming model M1 is nested in model M2, we can compute how
much the extra structure in M2 improves accuracy by
R2PE(u | t;M1,M2) = 1− P̂EM2(u | t)
/
P̂EM1(u | t)
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or
R2IPE(u | t;M1,M2) = 1− IP̂EM2(u | t)
/
IP̂EM1(u | t).
5 Analysis of the Aortic Valve Dataset
We return to the Aortic Valve dataset introduced in Section 1. Our aim is to use the
existing data and provide accurate predictions of re-operation-free survival for future patients
from the same population, utilizing their baseline information, namely age, gender, BMI
and the type of operation they underwent, and their recorded aortic gradient levels. In
our study, a total of 77 (27%) patients received a sub-coronary implantation (SI) and the
remaining 208 patients a root replacement (RR). These patients were followed prospectively
over time with annual telephone interviews and biennial standardized echocardiographic
assessment of valve function until July 8, 2010. Echo examinations were scheduled at 6
months and 1 year postoperatively, and biennially thereafter, and at each examination,
echocardiographic measurements of aortic gradient (mmHg) were taken. By the end of follow-
up, 1262 aortic gradient measurements were recorded with an average of 4.3 measurements
per patient (s.d. 2.4 measurements), 59 (20.7%) patients had died, and 73 (25.6%) patients
required a re-operation on the allograft. The composite event, re-operation or death, was
observed for 125 (43.9%) patients, and the corresponding Kaplan-Meier estimator for the
two intervention groups is shown in Figure 2. We can observe minimal differences in the
re-operation-free survival rates between sub-coronary implantation and root replacement,
with only a slight advantage of sub-coronary implantation towards the end of the follow-
up. For the longitudinal process and because aortic gradient exhibits right skewness, we will
proceed in our analysis using the square root transform of this outcome. Figure 3 depicts the
subject-specific longitudinal profiles of the square root aortic gradient for the two intervention
groups. We observe considerable variability in the shapes of these trajectories, but there are
no systematic differences apparent between the two groups.
We start by defining a set of joint models based on which predictions will be calculated.
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Figure 2: Kaplan-Meier estimates of the survival functions for re-operation-free survival for
the sub-coronary implantation (SI) and root replacement (RR) groups.
For the longitudinal process we allow a flexible specification of the subject-specific square
root aortic gradient trajectories using natural cubic splines of time. More specifically, the
linear mixed model takes the form
yi(t) = β1SIi + β2RRi + β3{B1(t, λ)× SIi}+ β4{B1(t, λ)× RRi}
+ β5{B2(t, λ)× SIi}+ β6{B2(t, λ)× RRi}
+ β7{B3(t, λ)× SIi}+ β8{B3(t, λ)× RRi}
+ bi0 + bi1B1(t, λ) + bi2B2(t, λ) + bi3B3(t, λ) + εi(t),
where Bn(t, λ) denotes the B-spline basis for a natural cubic spline with boundary knots
at baseline and 19 years and internal knots at 2.1 and 5.5 years (i.e., the 33.3% and 66.6%
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Figure 3: Subject-specific profiles for the square root aortic gradient separately for the sub-
coronary implantation (SI) and root replacement (RR) groups.
percentiles of the observed follow-up times), SI and RR are the dummy variables for the
sub-coronary implantation and root replacement groups, respectively, εi(t) ∼ N (0, σ2) and
bi ∼ N (0,D). For the survival process we consider four relative risk models, each positing
a different association structure between the two processes, namely:
M1 : hi(t) = h0(t) exp
{
γ1RRi + γ2Agei + γ3Femalei + γ4BMIi + α1mi(t)
}
,
M2 : hi(t) = h0(t) exp
{
γ1RRi + γ2Agei + γ3Femalei + γ4BMIi + α1mi(t) + α2m
′
i(t)
}
,
M3 : hi(t) = h0(t) exp
{
γ1RRi + γ2Agei + γ3Femalei + γ4BMIi + α1
∫ t
0
mi(s)ds
}
,
M4 : hi(t) = h0(t) exp
(
γ1RRi + γ2Agei + γ3Femalei + γ4BMIi + α1bi0 + α2bi1 + α3bi2 + α4bi3
)
,
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where the baseline hazard is approximated with B-splines, i.e.,
log h0(t) = γh0,0 +
Q∑
q=1
γh0,qBq(t,v),
with five internal knots placed at the corresponding percentiles of the observed event times,
and Female denotes the dummy variable for females. The estimation of these models was
based on a Bayesian approach and an MCMC algorithm with a single chain of 115,000
iterations from which we discarded the first 15,000 samples as burn-in. For all parameters
we took standard prior distributions (Ibrahim et al. 2001; Lesaffre and Lawson 2012). In
particular, for the vector of fixed effects of the longitudinal submodel β, the regression
parameters of the survival model γ, the vector of spline coefficients for the baseline hazard
γh0 , and for the association parameter α we used independent univariate diffuse normal
priors. For the variance of the error terms σ2 we take an inverse-Gamma prior, while for
covariance matrices we assumed an inverse Wishart prior. All computations have been
performed in R (version 3.0.1) using package JMbayes (version 0.4-1; Rizopoulos 2013) and
WinBUGS (version 1.4.3). Trace plots did not show any alarming indications of convergence
failure while auto-correlation plots showed relatively good mixing of the chains. Tables 1
and 2 show estimates and the corresponding 95% credible intervals for the parameters in the
longitudinal and survival submodels, respectively. We observe that the parameter estimates
in the relative risk models show greater variability between the posited association structures
(in particular between the time-dependent (M1, M2, and M3) and the time-independent
parameterizations (M4)) than the parameters in the linear mixed models. However, we
should note that the interpretation of the regression coefficients γ is not the same in the
four survival submodels because we condition on different components of the longitudinal
process.
To assess the predictive ability of the four joint models and compare them with the
landmark approach we consider the time interval [t = 7.5, u = 9.5] years. The reason
for choosing this interval is twofold. First, by time t = 7.5 years 75% of aortic gradient
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Table 1: Estimated coefficients and 95% credible intervals for the parameters of the longi-
tudinal submodels based on the four joint models fitted to the Aortic Valve dataset.
Value (M1) Value+Slope (M2) Area (M3) Shared RE (M4)
Est. 95% CI Est. 95% CI Est. 95% CI Est. 95% CI
SI 3.41 (3.055; 3.772) 3.38 (3.030; 3.718) 3.41 (3.047; 3.747) 3.38 (3.020; 3.733)
RR 2.86 (2.687; 3.028) 2.84 (2.671; 3.005) 2.87 (2.707; 3.038) 2.85 (2.682; 3.017)
SI:B-spln1 1.42 (0.885; 1.997) 1.51 (0.978; 2.048) 1.37 (0.840; 1.898) 1.59 (1.065; 2.163)
RR:B-spln1 1.38 (0.933; 1.815) 1.38 (0.927; 1.839) 1.42 (0.970; 1.859) 1.54 (1.096; 2.005)
SI:B-spln2 2.94 (1.867; 4.087) 3.19 (2.149; 4.113) 2.79 (1.874; 3.836) 3.62 (2.563; 4.745)
RR:B-spln2 2.57 (1.723; 3.510) 2.87 (1.978; 3.796) 2.32 (1.458; 3.158) 2.97 (2.089; 3.911)
SI:B-spln3 3.56 (2.585; 4.742) 3.81 (2.804; 4.787) 3.31 (2.417; 4.353) 4.44 (3.389; 5.672)
RR:B-spln3 2.36 (1.024; 3.736) 2.81 (1.433; 4.269) 1.94 (0.654; 3.211) 2.92 (1.574; 4.319)
σ 0.57 (0.542; 0.608) 0.58 (0.545; 0.613) 0.58 (0.545; 0.611) 0.58 (0.549; 0.617)
Table 2: Estimated coefficients and 95% credible intervals for the parameters of the survival
submodels (parameters γh0 of the baseline hazard have been omitted) based on the four joint
models fitted to the Aortic Valve dataset.
Value (M1) Value+Slope (M2) Area (M3) Shared RE (M4)
Est. 95% CI Est. 95% CI Est. 95% CI Est. 95% CI
RR 0.34 (−0.040; 0.739) 0.36 (−0.056; 0.790) 0.29 (−0.104; 0.688) −0.01 (−1.217; 1.112)
Age 0.01 (−0.001; 0.028) 0.02 (0.002; 0.034) 0.00 (−0.010; 0.018) 0.06 (0.022; 0.106)
Female −0.15 (−0.548; 0.225) −0.12 (−0.543; 0.275) −0.13 (−0.509; 0.243) −0.45 (−1.624; 0.567)
BMI −0.07 (−0.130; −0.019) −0.08 (−0.140; −0.023) −0.06 (−0.111; −0.002) −0.21 (−0.349; −0.095)
α1 0.37 (0.235; 0.496) 0.28 (0.106; 0.433) 0.03 (0.006; 0.044) −0.47 (−2.414; 1.543)
α2 1.47 (−0.261; 3.205) −4.14 (−7.931; −1.302)
α3 0.97 (−0.630; 3.130)
α4 2.53 (0.972; 4.383)
measurements have been recorded, and hence we have sufficient longitudinal information,
and second, a two-year interval is considered a medically relevant time frame within which
we would like to obtain accurate predictions of prognosis. For the 207 patients still at risk at
7.5 years we fitted three Cox models with corresponding association structures to the joint
models defined above (except from the random effects association structure), i.e.,
M5 : hi(u− 7.5) = h0(u− 7.5) exp
{
γ1RRi + γ2Agei + γ3Femalei + γ4BMIi + α1y˜i(7.5)
}
,
M6 : hi(u− 7.5) = h0(u− 7.5) exp
{
γ1RRi + γ2Agei + γ3Femalei + γ4BMIi
+ α1y˜i(7.5) + α2y˜
′
i(7.5)
}
,
M7 : hi(u− 7.5) = h0(u− 7.5) exp
{
γ1RRi + γ2Agei + γ3Femalei + γ4BMIi
+ α1
7.5∑
s=0
yi(s)∆s
}
,
where u > 7.5, variable y˜i(7.5) denotes the last available square root aortic gradient value
of each patient before year 7.5, y˜′i(7.5) denotes the slope defined from the last two avail-
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able measurements, and
∑
0≤s≤7.5 yi(s)∆s denotes the area under the step function defined
from the observed square root aortic gradient measurements up to 7.5 years. The parameter
estimates and confidence intervals of these Cox models are presented in Table 3. We eval-
Table 3: Estimated coefficients and 95% confidence intervals for the parameters in the Cox
models fitted to the patients at risk at t = 7.5 years.
Value (M5) Value+Slope (M6) Area (M7)
Est. 95% CI Est. 95% CI Est. 95% CI
RR 0.42 (−0.087; 0.930) 0.42 (−0.085; 0.927) 0.39 (−0.136; 0.907)
Age −0.01 (−0.025; 0.012) −0.01 (−0.024; 0.014) −0.01 (−0.026; 0.011)
Female −0.17 (−0.678; 0.347) −0.16 (−0.672; 0.352) −0.15 (−0.669; 0.363)
BMI 0.02 (−0.046; 0.093) 0.03 (−0.042; 0.097) 0.03 (−0.044; 0.094)
α1 0.02 (−0.187; 0.224) −0.01 (−0.221; 0.199) −0.01 (−0.047; 0.031)
α2 0.25 (−0.164; 0.669)
uate both discrimination and calibration using the predictive accuracy measures presented
in Section 4, namely P̂E(9.5|7.5), IP̂E(9.5|7.5), AÛC(9.5|7.5) and C∆t=2dyn . For the first two
the absolute loss function was used, and the calculation of Ĉ
∆t=2
dyn was based on the interval
[0, 15] years, with upper limit marking the 60% percentile of the event times distribution.
The estimates of these measures are presented in Table 4. With respect to accuracy we ob-
P̂E(9.5|7.5) IP̂E(9.5|7.5) AÛC(9.5|7.5) Ĉ∆t=2dyn
M1: JM value 0.1732 0.0904 0.6106 0.6433
M2: JM value+slope 0.1647 0.0855 0.5958 0.6592
M3: JM area 0.1525 0.0802 0.6090 0.5419
M4: JM shared RE 0.1133 0.0586 0.5755 0.6201
M5 : CoxLM value 0.1888 0.1032 0.5587 0.6338
M6 : CoxLM value+slope 0.1877 0.1025 0.5300 0.6238
M7 : CoxLM area 0.1885 0.1031 0.5739 0.5930
Table 4: Predictive performance measures for the Aortic Valve dataset under the four joint
models and the landmark approach based on Cox models with the analogous functional
forms. For P̂E(9.5|7.5) and IP̂E(9.5|7.5) the absolute loss function was used. Ĉ∆t=2dyn has
been calculated in the interval [0, 15] years.
serve that joint model M4 with the shared random-effects parameterization has the smallest
prediction error, followed by the other three joint models and the three Cox models using
the landmark approach. This is in terms of both accuracy of prediction at year 9.5 and the
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weighted average of prediction errors in the interval [7.5, 9.5]. With respect to discriminative
capability we observe that joint models M1 and M2 can best discriminate between patients
followed by the landmark approach and the other two joint models. The overall winner could
be deemed joint model M4, which has the best accuracy and respectable discriminative ca-
pability compared to the models that offer the best discrimination. A comparison between
the landmark approach and joint modeling in this particular dataset, and in particular when
we compare the same parameterization (i.e., models M1 vs. M5, M2 vs. M6 and M3 vs. M7),
reveals that the joint models perform better in terms of both accuracy and discrimination.
6 Simulations
6.1 Design
We performed a series of simulations to landmarking with joint models in the context of
dynamic predictions. The design of our simulation study is motivated by the set of joint
models fitted to the Aortic Valve dataset in Section 5. In particular, we assume 300 patients
who have been followed-up for a period of 19 years, and were planned to provide longitudinal
measurements at baseline and afterwards at nine random follow-up times. For the longitu-
dinal process, and similarly to the model fitted in the Aortic Valve dataset, we used natural
cubic splines of time with two internals knots placed at 2.1 and 5.5 years, and boundary
knots placed at baseline and 19 years, i.e., the form of the model is as follows
yi(t) = β1Trt0i + β2Trt1i + β3{B1(t,λ)× Trt0i}+ β4{B1(t,λ)× Trt1i}
+ β5{B2(t,λ)× Trt0i}+ β6{B2(t,λ)× Trt1i}
+ β7{B3(t,λ)× Trt0i}+ β8{B3(t,λ)× Trt1i}
+ bi0 + bi1B1(t,λ) + bi2B2(t,λ) + bi3B3(t,λ) + εi(t),
where Bn(t,λ) denotes the B-spline basis for a natural cubic spline with λ = (0, 2.1, 5.5, 19),
Trt0 and Trt1 are the dummy variables for the two treatment groups, εi(t) ∼ N (0, σ2) and
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bi ∼ N (0,D) with D taken to be diagonal.
For the survival process, we have assumed four scenarios, each one corresponding to a
different functional form for the association structure between the two processes. Motivated
by the arguments set forth in Section 2.3, we simulated survival data under the joint modeling
framework (i.e., not assuming that the biomarker’s levels are constant between the visit
times). More specifically,
Scenario I: hi(t) = h0(t) exp
{
γ0 + γ1Trt1i + α1mi(t)
}
,
Scenario II: hi(t) = h0(t) exp
{
γ0 + γ1Trt1i + α1mi(t) + α2m
′
i(t)
}
,
Scenario III: hi(t) = h0(t) exp
{
γ0 + γ1Trt1i + α1
∫ t
0
mi(s)ds
}
,
Scenario IV: hi(t) = h0(t) exp
(
γ0 + γ1Trt1i + α1bi0 + α2bi1 + α3bi2 + α4bi3
)
,
with h0(t) = σtt
σt−1, i.e., the Weibull baseline hazard. The values for the regression coef-
ficients in the longitudinal and survival submodels, the variance of the error terms of the
mixed model, the covariance matrix for the random effects, and the scale of the Weibull
baseline risk function are given in Appendix A, and have been chosen such that the distribu-
tion of the event times and the distribution of the follow-up longitudinal measurements were
comparable across scenarios. Censoring times were simulated from a uniform distribution in
(0, tC) with tC set to result in about 45% censoring in each scenario. For each scenario we
simulated 200 datasets.
6.2 Results
Mimicking the real-life use of a prognostic model, and to assess any potential overfitting
issues, the comparison between the landmark and joint modeling approaches is based on
subjects who were not used in fitting the corresponding models. More specifically, under
each scenario and for each simulated dataset, we randomly excluded ten subjects whose
event times were censored. For these subjects we set as landmark time the time point
of their last longitudinal measurement, and produce survival probabilities from that point
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onwards to the end of the follow-up. Under the landmark approach these probabilities are
based on the following relative risk models fitted to the remaining subjects:
LM1 : hi(u− tLM) = h0(u− tLM) exp
{
γ0 + γ1Trt1i + α1y˜i(tLM)
}
,
LM2 : hi(u− tLM) = h0(u− tLM) exp
{
γ0 + γ1Trt1i + α1y˜i(tLM) + α2y˜
′
i(tLM)
}
,
LM3 : hi(u− tLM) = h0(u− 7.5) exp
{
γ0 + γ1Trt1i + α1
tLM∑
s=0
yi(s)∆s
}
,
where tLM denotes the landmark time, and as before, y˜i(tLM) denotes the last available
measurement of subject i before tLM , y˜
′
i(tLM) denotes the slope defined from the last two
available measurements, and
tLM∑
s=0
yi(s)∆s the area under the step function defined from the
observed longitudinal responses up to tLM . Similarly, we also fitted four joint models to the
remaining 290 subjects, with the same longitudinal submodel as the one we simulated from,
and survival submodels:
JM1 : hi(t) = h0(t) exp
{
γ0 + γ1Trt1i + α1mi(t)
}
,
JM2 : hi(t) = h0(t) exp
{
γ0 + γ1Trt1i + α1mi(t) + α2m
′
i(t)
}
,
JM3 : hi(t) = h0(t) exp
{
γ0 + γ1Trt1i + α1
∫ t
0
mi(s) ds
}
,
JM4 : hi(t) = h0(t) exp
(
γ0 + γ1Trt1i + α1bi0 + α2bi1 + α3bi2 + α4bi3
)
,
based on which survival probabilities were derived. Due to the fact that our aim here is
to investigate the impact on predictions of the underlying differences between landmarking
and joint modeling, as explained in Section 2.3, in both approaches the baseline hazard is
assumed of the Weibull form, i.e., h0(t) = σtt
σt−1 with σt denoting the shape parameter and
the intercept term γ0 the log scale parameter.
Based on the seven models, predictions were calculated for each of the ten subjects we
have originally excluded, at ten equidistant time points between their last available longi-
tudinal measurement and the end of follow-up. To evaluate the accuracy of these predicted
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survival probabilities we compared them with the gold standard survival probabilities, which
are calculated as Sj
{
u | Mj(u, bj),θ
}
/Sj
{
t | Mj(t, bj),θ
}
, using the true parameter values
and the true values of the random effects for the subjects we excluded. Hence, in each sim-
ulated dataset and for each of the ten subjects, we calculated root mean squared prediction
errors (RMSEs) between the gold standard survival probabilities and the predictions under
the seven models. The RMSEs over all the subjects from the 200 datasets are shown in
Figure 4. The results suggest that the joint modeling approach seems to give more accurate
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Figure 4: Simulation results under the four scenarios based on 200 datasets. Each boxplot
shows the distribution of the root mean squared predictions error of the corresponding model
to compute predictions versus the gold standard.
predictions than landmarking. More noticeable are the differences in Scenarios I, II and IV
while in Scenario III both approaches gave similarly accurate results.
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7 Discussion
In this work we have contrasted and compared two popular approaches, namely landmarking
and joint modeling, for producing dynamically-updated predictions of survival probabilities
with time-dependent covariates. Landmarking can effortlessly be implemented in practice
but it makes strong assumptions regarding the path of the time-dependent covariates, which
may be unrealistic for longitudinal biomarker measurements. On the other hand, joint mod-
eling allows for greater flexibility in the attributes of time-dependent covariate process, but
requires more modeling assumptions to achieve this and is generally more computationally
intensive. Our simulation study and the analysis of the motivating Aortic Valve dataset have
shown that, in general, there is a gain from considering the joint modeling approach instead
of landmarking.
In our developments we have only focused on a single continuous longitudinal biomarker.
However, often in practice and in order to obtain a more complete picture of the progres-
sion of a patient, several biomarkers are recorded, which could be of either continuous or
categorical nature. In this more complex setting landmarking is advantageous because it
is straightforward to include extra markers as baseline covariates in the linear predictor of
the Cox model fitted to the patients at risk at the landmark point. On the contrary, the
joint modeling approach requires a model specification for each marker. Mathematically and
under the conditional independence assumptions (4) and (5) this relatively easily achieved
by considering the framework of generalized linear mixed effects models (Breslow and Clay-
ton 1993). From the practical side, however, the dimensionality of the random effects may
increase considerably, making joint models harder to fit. Previous and recent work by the
first author is focused on resolving this problem by making use of Laplace approximations
and efficient Gaussian quadrature rules (Rizopoulos et al. 2009; Rizopoulos 2012a). In ad-
dition, in our analysis of the Aortic Valve dataset we have considered the composite event
re-operation or death (whatever comes first), but for the treating physicians it could be of
interest to have risk estimates separately for the two events. In this case we can extend both
landmarking and joint modeling to the competing risks setting and derive estimates of the
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corresponding cumulative incidence functions. A general challenge when either or both of the
two extensions (i.e., multiple longitudinal outcomes or multiple event times) are considered
is the number of possible models. In particular, following the discussion in Section 3 and the
different possibilities we have in building the functional relationship between the longitudinal
and time-to-event outcomes, it is evident that when we move to the multivariate setting, the
choice of the appropriate parameterization for each longitudinal outcome and eventually for
each competing risk becomes a demanding model-selection exercise.
Regarding the software implementation of the methodology presented in the paper, the
landmark approach is readily available in all statistical software that fit Cox models. The fit-
ting of joint models, the derivation of dynamic predictions (for the survival and longitudinal
outcomes) and the calculation of the calibration and discrimination measures presented in
Section 4 are implemented in the freely available R packages JM (Rizopoulos 2010, 2012b)
and JMbayes (Rizopoulos 2013), which can be downloaded from CRAN at http://cran.
r-project.org/package=JM and http://cran.r-project.org/package=JMbayes, respec-
tively.
A Simulation Settings
For all simulation scenarios the parameter values that were used for the longitudinal sub-
model were
Fixed effects: β1 = 0.93, β2 = −0.6, β3 = 0.63, β4 = 0.42, β5 = 1.1, β6 = 0.54,
β7 = 0.54, and β8 = 0.55;
Random effects diagonal covariance matrix: D11 = 0.49, D22 = 4.52, D33 = 2.33, and
D44 = 1.52;
Measurement error standard deviation: σ = 2.
For the survival submodels the parameters that were used to simulate from each scenario
are given in Table 5.
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Scenario
I II III IV
γ0 −6.73 −6.73 −6.73 −6.73
γ1 0.41 0.41 0.41 0.41
α1 0.7 0.05 0.08 −0.3
α2 3.3 −0.8
α3 0.3
α4 0.8
σt 1.65 1.65 1.65 1.60
Table 5: Parameter values for the survival submodels under the four simulation scenarios.
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